Clinical trial
Assessment of the Performance of the Tasman CPAP System in Treating Obstructive Sleep Apnea
NCT01171066 is registered in ClinicalTrials.gov with ResMed as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of the Performance of the Tasman CPAP System in Treating Obstructive Sleep Apnea
- Lead sponsor
- ResMed
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 30, 2010
- Completion date
- October 31, 2012
- Enrollment
- 57 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
obstructive sleep apnea